Patents by Inventor Kenneth Trofatter

Kenneth Trofatter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210110561
    Abstract: A method for acquiring body measurement information includes: detecting that a subject is in proximity to a flat-panel imaging device; capturing, via the flat-panel imaging device, a plurality of images; processing the plurality of images to build a three-dimensional model of the subject; calculating one or more body measurements of the subject based on the three-dimensional model; and outputting the one or more body measurements.
    Type: Application
    Filed: October 9, 2020
    Publication date: April 15, 2021
    Inventors: Jonah Gollub, Kenneth Trofatter, Seyedmohammadreza Faghih Imani, David R. Smith
  • Patent number: 6706728
    Abstract: A system for treating a condition associated with a mucosal surface, the system comprising an immune response modifier (IRM) compound chosen from imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, 1,2-bridged imidazoquinoline amines, and pharmaceutically acceptable salts thereof and an applicator device for applying the IRM compound to the mucosal surface. This system of IRM compounds and applicator may be used to treat conditions associated with mucosal surfaces such as cervical dysphasia and cervical intraepithelial neoplasia.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: March 16, 2004
    Assignee: 3M Innovative Properties Company
    Inventors: John C. Hedenstrom, Michael J. Jozwiakowski, Mark Martinez, Kenneth R. Phares, Kenneth Trofatter, Jr.
  • Publication number: 20030045543
    Abstract: A system for treating a condition associated with a mucosal surface, the system comprising an immune response modifier (IRM) compound chosen from imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, 1,2-bridged imidazoquinoline amines, and pharmaceutically acceptable salts thereof and an applicator device for applying the IRM compound to the mucosal surface. This system of IRM compounds and applicator may be used to treat conditions associated with mucosal surfaces such as cervical dysphasia and cervical intraepithelial neoplasia.
    Type: Application
    Filed: September 10, 2002
    Publication date: March 6, 2003
    Applicant: 3M Innovative Properties Company
    Inventors: John C. Hedenstrom, Michael J. Jozwiakowski, Mark Martinez, Kenneth R. Phares, Kenneth Trofatter
  • Publication number: 20020058674
    Abstract: A system for treating a condition associated with a mucosal surface, the system comprising an immune response modifier (IRM) compound chosen from imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, 1,2-bridged imidazoquinoline amines, and pharmaceutically acceptable salts thereof and an applicator device for applying the IRM compound to the mucosal surface. This system of IRM compounds and applicator may be used to treat conditions associated with mucosal surfaces such as cervical dysphasia and cervical intraepithelial neoplasia.
    Type: Application
    Filed: June 22, 2001
    Publication date: May 16, 2002
    Inventors: John C. Hedenstrom, Michael J. Jozwiakowski, Mark Martinez, Kenneth R. Phares, Kenneth Trofatter